Dr. Shailesh Ayyangar has been on the Board since 2021. He is having over 35 years of experience in healthcare, has gained deep experience in Pharmaceutical R&D, Biologicals, Pharmaceutical operations, Animal Health, Consumer Healthcare & Strategic M&A. He has been associated in building businesses and launching some of the biggest brands in healthcare industry.

For nearly 18 years, Dr. Ayyangar was the member of International Leadership Team and Country Chair for India & South Asia running all business interests of the Sanofi Group including Pharmaceuticals, Specialty care, Vaccines, Animal Health and Consumer Healthcare. He built the business from its infancy to bringing it to be amongst the most respected and fast growing MNCs in India & South Asia. He was also involved in global & national M&A activities and innovative partnerships (Apollo Sugar Clinics). One of the longest serving Country Chairs in the country and region.

Dr. Ayyangar served 14 years at GSK, during which he was the Head of Tropical Medicine R&D group in the United Kingdom for 5 years and Exec VP, GSK India & MD, Bangladesh. Currently, Dr. Ayyangar is a Senior Advisor at Goldman Sachs Life Sciences Council, Member of the Board of Governors at IIM, Ranchi, Member of the Governing Council at the Cancer Cure Fund of Indian Cancer Society, Chairman of the Noveltech Feeds Private Limited (Fully Owned sub of Goldman Sachs) and Independent Director at the Shaily Engineering and Plastics Limited, Baroda

Dr. Ayyangar is a Doctor of Veterinary Medicine (Gujarat Veterinary College, Anand, India), has a Post Graduate Diploma in Management (MBA) from IIM, Ahmedabad, India and has also completed the Advance Management Program (AMP) from INSEAD, Fontainblue, France.

Dr. Ayyangar is also the recipient of one of the highest civilian awards from President of France: “Officier de l’ordre national du merite”, 2016.